Prevention of allergic asthma through der p 2 peptide vaccination

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 1, 2015, Pages 197-200.e1

  Bouchaud, Gregory ^a,b,c,d,e   Braza, Faouzi ^a,b,c,d   Chesné, Julie ^a,b,c,d   Lair, David ^a,b,c,d   Chen, Kuan Wei ^f   Rolland Debord, Camille ^a,b,c,d   Hassoun, Dorian ^a,b,c,d   Roussey Bihouée, Tiphaine ^a,b,c,d   Cheminant, Marie Aude ^a,b,c,d   Brouard, Sophie ^c,g,h   Bodinier, Marie ^e   Vrtala, Susanne ^f   Magnan, Antoine ^a,b,c,d  

^a L INSTITUT DU THORAX   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d DHU2020 Médecine Personnalisée des Maladies Chroniques   (France)

^e INRA   (France)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g INSERM   (France)

^h HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOPHAGOIDES PTERONYSSINUS ALLERGEN 2.1 PEPTIDE; DERMATOPHAGOIDES PTERONYSSINUS ALLERGEN 2.2 PEPTIDE; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 4; METHACHOLINE; PEPTIDE VACCINE; UNCLASSIFIED DRUG; ARTHROPOD PROTEIN; DERMATOPHAGOIDES PTERONYSSINUS ANTIGEN P 2; PEPTIDE;

ALLERGENICITY; ALLERGIC ASTHMA; ASTHMA; BRONCHOCONSTRICTION; CELL INFILTRATION; CROSS REACTION; EOSINOPHIL; GENETIC ENGINEERING; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; IMMUNOTHERAPY; IN VIVO STUDY; LETTER; LUNG FUNCTION; LUNG LAVAGE; LUNG RESISTANCE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; T LYMPHOCYTE; VACCINATION; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DRUG EFFECTS; FEMALE; IMMUNOLOGY; MOLECULAR GENETICS; MOUSE; PYROGLYPHIDAE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ARTHROPOD PROTEINS; ASTHMA; CELL MOVEMENT; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; PYROGLYPHIDAE; VACCINATION;

EID: 84949115009     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.12.1938     Document Type: Article

References (14)

1. P.J. Bousquet, S. Chinn, C. Janson, M. Kogevinas, P. Burney, D. Jarvis, and et al. Geographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey I Allergy 62 2007 301 309
2. C.H. Meyer, J.F. Bond, M.S. Chen, and M.T. Kasaian Comparison of the levels of the major allergens Der p I and Der p II in standardized extracts of the house dust mite, Dermatophagoides pteronyssinus Clin Exp Allergy 24 1994 1041 1048
3. J.S. van der Zee, P. van Swieten, H.M. Jansen, and R.C. Aalberse Skin tests and histamine release with P1-depleted Dermatophagoides pteronyssinus body extracts and purified P1 J Allergy Clin Immunol 81 1988 884 896
4. R. Valenta, F. Ferreira, M. Focke-Tejkl, B. Linhart, V. Niederberger, I. Swoboda, and et al. From allergen genes to allergy vaccines Annu Rev Immunol 28 2010 211 241
5. K.W. Chen, K. Blatt, W.R. Thomas, I. Swoboda, P. Valent, R. Valenta, and et al. Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy J Allergy Clin Immunol 130 2012 435 443.e4
6. K.W. Chen, M. Focke-Tejkl, K. Blatt, M. Kneidinger, A. Gieras, F. Dall'Antonia, and et al. Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients Allergy 67 2012 609 621
7. K. Botturi, M. Langelot, D. Lair, A. Pipet, M. Pain, J. Chesne, and et al. Preventing asthma exacerbations: what are the targets? Pharmacol Ther 131 2011 114 129
8. B. Linhart, M. Narayanan, M. Focke-Tejkl, F. Wrba, S. Vrtala, and R. Valenta Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy Clin Exp Allergy 44 2014 278 287
9. P.W. Heymann, M.D. Chapman, R.C. Aalberse, J.W. Fox, and T.A. Platts-Mills Antigenic and structural analysis of group II allergens (Der f II and Der p II) from house dust mites (Dermatophagoides spp) J Allergy Clin Immunol 83 1989 1055 1067
10. F. Braza, J. Chesne, S. Castagnet, A. Magnan, and S. Brouard Regulatory functions of B cells in allergic diseases Allergy 69 2014 1454 1463
11. M. Akdis, and C.A. Akdis Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens J Allergy Clin Immunol 133 2014 621 631
12. W. van de Veen, B. Stanic, G. Yaman, M. Wawrzyniak, S. Sollner, D.G. Akdis, and et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses J Allergy Clin Immunol 131 2013 1204 1212
13. J. Chesné, F. Braza, G. Mahay, S. Brouard, M. Aronica, and A. Magnan IL-17 in severe asthma: where do we stand? Am J Respir Crit Care Med 190 2014 1094 1101
14. K.W. Chen, G. Fuchs, K. Sonneck, A. Gieras, I. Swoboda, N. Douladiris, and et al. Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering Mol Immunol 45 2008 2486 2498